<?xml version="1.0" encoding="UTF-8"?>
<document id="28328135">
	<sentence id="s1" text="Since the original description of the isoleucyl-tRNA aminoacylation-related cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, skeletal dysplasia syndrome (CAGSSS; OMIM 616007) in an extended consanguineous family of French-Canadian descent, no further patients have been reported.">
		<entity id="s1.e1" charOffset="38-67"
			type="GO" text="isoleucyl-tRNA aminoacylation" ontology_id="GO_0006428"/>
		<entity id="s1.e2" charOffset="76-85"
			type="HP" text="cataracts" ontology_id="HP_0000518"/>
		<entity id="s1.e3" charOffset="122-132"
			type="HP" text="neuropathy" ontology_id="HP_0009830"/>
		<entity id="s1.e4" charOffset="148-160"
			type="HP" text="hearing loss" ontology_id="HP_0000365"/>
		<entity id="s1.e5" charOffset="162-180"
			type="HP" text="skeletal dysplasia" ontology_id="HP_0002652"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="true"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e3" pgr="true"/>
		<pair id="s1.p3" e1="s1.e1"
		    e2="s1.e4" pgr="true"/>
		<pair id="s1.p4" e1="s1.e1"
		    e2="s1.e5" pgr="true"/>
	</sentence>
	<sentence id="s2" text="Here, we report on a female Danish patient with a novel homozygous isoleucyl-tRNA aminoacylation mutation, p.Gly874Arg, who presented at birth with bilateral negative regulation of signal transduction dislocation and short stature.">
		<entity id="s2.e1" charOffset="67-96"
			type="GO" text="isoleucyl-tRNA aminoacylation" ontology_id="GO_0006428"/>
		<entity id="s2.e2" charOffset="158-200"
			type="GO" text="negative regulation of signal transduction" ontology_id="GO_0009968"/>
		<entity id="s2.e3" charOffset="178-191"
			type="HP" text="short stature" ontology_id="HP_0004322"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e3" pgr="true"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e3" pgr="false"/>
	</sentence>
	<sentence id="s3" text="At 3 months, additional dysmorphic features were noted and at 18 months her radiographic skeletal abnormalities were suggestive of an underlying spondyloepimetaphyseal dysplasia (regulation of axon extension involved in axon guidance).">
		<entity id="s3.e1" charOffset="89-111"
			type="HP" text="skeletal abnormalities" ontology_id="HP_0000924"/>
		<entity id="s3.e2" charOffset="145-177"
			type="HP" text="spondyloepimetaphyseal dysplasia" ontology_id="HP_0002651"/>
		<entity id="s3.e3" charOffset="179-233"
			type="GO" text="regulation of axon extension involved in axon guidance" ontology_id="GO_0048841"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e3" pgr="true"/>
		<pair id="s3.p2" e1="s3.e2"
		    e2="s3.e3" pgr="false"/>
	</sentence>
	<sentence id="s4" text="We present her clinical features and particularly highlight her skeletal findings, which confirm the presence of a primary regulation of axon extension involved in axon guidance skeletal dysplasia in a growing list of mitochondrial-related disorders including CAGSSS, CODAS, EVEN-PLUS, and X-linked SEMD-transcription initiation from RNA polymerase II promoter syndromes">
		<entity id="s4.e1" charOffset="123-177"
			type="GO" text="regulation of axon extension involved in axon guidance" ontology_id="GO_0048841"/>
		<entity id="s4.e2" charOffset="178-196"
			type="HP" text="skeletal dysplasia" ontology_id="HP_0002652"/>
		<entity id="s4.e3" charOffset="304-360"
			type="GO" text="transcription initiation from RNA polymerase II promoter" ontology_id="GO_0006367"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e2" pgr="true"/>
		<pair id="s4.p2" e1="s4.e2"
		    e2="s4.e3" pgr="false"/>
	</sentence>
</document>
